Castle Biosciences Adds Mental Health Testing Solutions Via AltheaDx Acquisition Castle Biosciences Inc (NASDAQ: CSTL) has agreed to acquire AltheaDx Inc, a commercial-stage molecular diagnostics company, Benzinga · Apr 5, 2022